Cite
HARVARD Citation
Volkmann, E. et al. (n.d.). OP0124 Treatment with cyclophosphamide for systemic sclerosis-related interstitial lung disease does not improve survival after 12 years of follow up. Annals of the rheumatic diseases. p. 104. [Online].